Interestingly, ZEB1 inhibits cell polarity in lung cancer cells, at least in part, by relieving miR200-mediated mRNA degradation of KIF13A and AP1S2, thus accelerating the endocytic transport of extracellular plasma membrane-bound proteins69. Here, ZEB1 is linked to lung carcinoma.